Dr. Hu Hao, a researcher specializing in the fields of biostatistics, health economics and outcomes research. He holds a Ph.D. in Pharmacy from the University of Newcastle, Australia, and dual master’s degrees in Bioinformatics and Biostatistics from the Catholic University of Leuven, Belgium. 

Dr. Hu Hao currently holds positions as a Research Fellow in the Global Health Research Center at Duke Kunshan University. He also serves as a committee member for the Health Technology Assessment Committee of the Chinese Society of Health Economics and the Medical Insurance Research Committee of the Chinese Social Insurance Society. Furthermore, he is the Director of the Health Data Research Center at the Medical Devices Committee of the China Association of Enterprises with Foreign Investment. 

Dr. Hu Hao has over a decade of professional experience in the pharmaceutical industry, focusing on new drug development and market access. His career includes senior roles in biostatistics, pharmacoeconomics, and outcomes research with several leading multinational pharmaceutical companies and CROs including IQVIA, Servier, and Gilead.